share_log

Marpai | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Marpai | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Marpai | S-8:員工福利計劃證券登記
美股sec公告 ·  05/23 04:05
牛牛AI助理已提取核心訊息
Marpai, Inc., a health tech company, filed a Form S-8 registration statement with the Securities and Exchange Commission (SEC) on May 22, 2024. The filing pertains to the Marpai, Inc. 2024 Global Stock Incentive Plan, which is designed to offer stock incentives to employees. The company, headquartered in Tampa, Florida, is classified as a non-accelerated filer, smaller reporting company, and emerging growth company under SEC regulations. The registration statement includes references to previously filed documents, such as the company's Annual Report on Form 10-K for the year ended December 31, 2023, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2024. Marpai's CEO, Damien Lamendola, is named as the agent for service in the filing. The company has also incorporated by...Show More
Marpai, Inc., a health tech company, filed a Form S-8 registration statement with the Securities and Exchange Commission (SEC) on May 22, 2024. The filing pertains to the Marpai, Inc. 2024 Global Stock Incentive Plan, which is designed to offer stock incentives to employees. The company, headquartered in Tampa, Florida, is classified as a non-accelerated filer, smaller reporting company, and emerging growth company under SEC regulations. The registration statement includes references to previously filed documents, such as the company's Annual Report on Form 10-K for the year ended December 31, 2023, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2024. Marpai's CEO, Damien Lamendola, is named as the agent for service in the filing. The company has also incorporated by reference its recent Current Reports on Form 8-K and the description of the company's Common Stock from a previous registration statement. The document outlines the company's indemnification policies for directors and officers, in accordance with Delaware law, and mentions the maintenance of director and officer liability insurance. The filing does not claim exemption from registration and includes a list of exhibits related to the company's corporate governance documents and the 2024 Global Stock Incentive Plan.
健康科技公司Marpai, Inc. 於2024年5月22日向美國證券交易委員會(SEC)提交了S-8表格註冊聲明。該文件與Marpai, Inc. 2024年全球股票激勵計劃有關,該計劃旨在爲員工提供股票激勵。該公司總部位於佛羅里達州坦帕市,根據美國證券交易委員會的規定,該公司被歸類爲非加速申報人、小型申報公司和新興成長型公司。註冊聲明中提到了先前提交的文件,例如公司截至2023年12月31日止年度的10-K表年度報告和截至2024年3月31日的季度的10-Q表季度報告。Marpai的首席執行官達米安·拉門多拉在文件中被指定爲服務代理人。該公司還以引用方式納入了其最近的8-K表最新報告以及先前註冊聲明中對公司普通股的描述。該文件概述了公司根據特拉華州法律對董事和高級管理人員的賠償政策,並提到了維持董事和高級管理人員責任保險的問題。該文件並未申請註冊豁免,幷包括與公司治理文件和2024年全球股票激勵計劃相關的證物清單。
健康科技公司Marpai, Inc. 於2024年5月22日向美國證券交易委員會(SEC)提交了S-8表格註冊聲明。該文件與Marpai, Inc. 2024年全球股票激勵計劃有關,該計劃旨在爲員工提供股票激勵。該公司總部位於佛羅里達州坦帕市,根據美國證券交易委員會的規定,該公司被歸類爲非加速申報人、小型申報公司和新興成長型公司。註冊聲明中提到了先前提交的文件,例如公司截至2023年12月31日止年度的10-K表年度報告和截至2024年3月31日的季度的10-Q表季度報告。Marpai的首席執行官達米安·拉門多拉在文件中被指定爲服務代理人。該公司還以引用方式納入了其最近的8-K表最新報告以及先前註冊聲明中對公司普通股的描述。該文件概述了公司根據特拉華州法律對董事和高級管理人員的賠償政策,並提到了維持董事和高級管理人員責任保險的問題。該文件並未申請註冊豁免,幷包括與公司治理文件和2024年全球股票激勵計劃相關的證物清單。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。